Table 1. Overall clinical characteristics of the study subjects.
Variables | Pre-correction | Post-correction | P |
---|---|---|---|
Age (year), mean ± SD | 13.6±6.5 | 15.71±6.6 | <0.001 |
Sex, n | |||
Male | 71 | ||
Female | 14 | ||
Morphology type, n | <0.001 | ||
Symmetric | 54 | 85 | |
Asymmetric | 31 | 0 | |
Age group, n | 1.000 | ||
YG (<10 years old) | 24 | 23 | |
OG (≥10 years old) | 61 | 62 | |
LDH, mean ± SD | |||
Total LDH (IU/L) | 404.2±80.8 | 369.2±79.3 | <0.001 |
LDH1 (17.7–31.5%) | 26.4±3.2 | 27.2±2.9 | 0.057 |
LDH2 (28.0–35.7%) | 30.9±3.8 | 30.8±2.5 | 0.777 |
LDH3 (20.8–26.8%) | 21.2±2.3 | 20.8±2.2 | 0.744 |
LDH4 (6.4–12.7%) | 8.8±2.7 | 8.4±2.7 | 0.326 |
LDH5 (4.5–16.0%) | 13.2±3.4 | 13.6±4.5 | 0.541 |
Haller index, mean ± SD | 3.8±1.45 | 2.7±0.4 | <0.001 |
LDH, lactate dehydrogenase; YG, young group; OG, old group.